Categories
Change Password!
Reset Password!
Using REAC treatments in fibromyalgia patients may prove to be a potent strategy, lessening the overreliance on pain-relieving medications while enhancing their ability to engage in daily activities.
In a recent study, radioelectric asymmetric conveyer (REAC) therapies demonstrated potential as an effective intervention for individuals with fibromyalgia syndrome, decreasing the overreliance on analgesic medications and enhancing daily activities. The study's objective was to examine the influence of various REAC treatments on the quality of life and psychomotor responses in fibromyalgia patients.
The study included a total of 37 participants, who underwent assessments both prior to and following a single session of neuro postural optimization. Additionally, evaluations were conducted following eighteen sessions of neuro psycho-physical optimization. Various tests were employed to measure motor function, including the assessment of functional dysmetria phenomenon, Sitting and Standing tests, and the Time Up and Go test.
Utilizing the fibromyalgia impact questionnaire, the assessment of quality of life was done. After conducting a statistical analysis of the data, the findings revealed a significant enhancement in motor responses and various quality of life parameters, such as pain reduction and improved functional dysmetria measures, among all participants.
The therapeutic protocols of neuro postural optimization and neuro psycho physical optimization established a neurobiological balance, effectively addressing the maladaptive state resulting from exposomal and environmental stress in individuals with fibromyalgia syndrome. As a result, there was an improvement observed in psychomotor responses and overall quality of life. Hence, the usage of safe and imperceptible non-invasive neurobiological modulation therapies appears to be a favorable precision medicine approach for individuals suffering from fibromyalgia.
Journal of Personalized Medicine
REAC Neurobiological Modulation as a Precision Medicine Treatment for Fibromyalgia
Analízia Silva et al.
Comments (0)